Novel Coronavirus and Its Potential Risk of Triggering Inflammatory Disease of the Abdomen during COVID-19: Endoscopic Application

Detalles Bibliográficos
Autor principal: Yu, Xianqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Endoscopy and Imaging: Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678228/
https://www.ncbi.nlm.nih.gov/pubmed/34350855
http://dx.doi.org/10.1159/000518851
_version_ 1784616291291627520
author Yu, Xianqiang
author_facet Yu, Xianqiang
author_sort Yu, Xianqiang
collection PubMed
description
format Online
Article
Text
id pubmed-8678228
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-86782282021-12-17 Novel Coronavirus and Its Potential Risk of Triggering Inflammatory Disease of the Abdomen during COVID-19: Endoscopic Application Yu, Xianqiang Dig Dis Endoscopy and Imaging: Letter to the Editor S. Karger AG 2021-08-04 /pmc/articles/PMC8678228/ /pubmed/34350855 http://dx.doi.org/10.1159/000518851 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Endoscopy and Imaging: Letter to the Editor
Yu, Xianqiang
Novel Coronavirus and Its Potential Risk of Triggering Inflammatory Disease of the Abdomen during COVID-19: Endoscopic Application
title Novel Coronavirus and Its Potential Risk of Triggering Inflammatory Disease of the Abdomen during COVID-19: Endoscopic Application
title_full Novel Coronavirus and Its Potential Risk of Triggering Inflammatory Disease of the Abdomen during COVID-19: Endoscopic Application
title_fullStr Novel Coronavirus and Its Potential Risk of Triggering Inflammatory Disease of the Abdomen during COVID-19: Endoscopic Application
title_full_unstemmed Novel Coronavirus and Its Potential Risk of Triggering Inflammatory Disease of the Abdomen during COVID-19: Endoscopic Application
title_short Novel Coronavirus and Its Potential Risk of Triggering Inflammatory Disease of the Abdomen during COVID-19: Endoscopic Application
title_sort novel coronavirus and its potential risk of triggering inflammatory disease of the abdomen during covid-19: endoscopic application
topic Endoscopy and Imaging: Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678228/
https://www.ncbi.nlm.nih.gov/pubmed/34350855
http://dx.doi.org/10.1159/000518851
work_keys_str_mv AT yuxianqiang novelcoronavirusanditspotentialriskoftriggeringinflammatorydiseaseoftheabdomenduringcovid19endoscopicapplication

Ejemplares similares